Review



ampakine cx614  (Tocris)


Bioz Verified Symbol Tocris is a verified supplier
Bioz Manufacturer Symbol Tocris manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Tocris ampakine cx614
    Figure 4. Respiratory depression and respiratory stimulants in larval zebrafish. (A) The respiratory stimulant BIMU8 (10 mM), a 5-HT4A serotonin receptor agonist, in combination with fentanyl (n = 20) was compared to fentanyl alone (n = 4) or BIMU8 alone (n = 21). BIMU8 was not sufficient to reverse respiratory depression by fentanyl. (B) The AMPA positive allosteric modulator <t>CX614</t> (5 mM) and fentanyl (n = 6) were also compared to fentanyl alone (n = 7) or control (n = 7). CX614 + fentanyl group showed significantly higher respiratory rate than fentanyl, DMSO, and control. (C) The analgesic lidocaine (n = 4) was compared to DMSO (0.0016%) (n = 5) and control (n = 5) and showed lower respiratory rate than the control group. Normalized data are presented as means ± standard deviations. Circles indicate individual data points for each zebrafish measured. Black lines and * indicate groups significantly different with p<0.05. Source data can be found in Figure 4—source data 1. The online version of this article includes the following source data for figure 4:
    Ampakine Cx614, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 12 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ampakine+cx614/CX+614/10__7554_slash_elife__63407-303-7-18
    Average 93 stars, based on 12 article reviews
    ampakine cx614 - by Bioz Stars, 2026-09
    93/100 stars

    Images

    1) Product Images from "Respiratory depression and analgesia by opioid drugs in freely behaving larval zebrafish"

    Article Title: Respiratory depression and analgesia by opioid drugs in freely behaving larval zebrafish

    Journal: eLife

    doi: 10.7554/elife.63407

    Figure 4. Respiratory depression and respiratory stimulants in larval zebrafish. (A) The respiratory stimulant BIMU8 (10 mM), a 5-HT4A serotonin receptor agonist, in combination with fentanyl (n = 20) was compared to fentanyl alone (n = 4) or BIMU8 alone (n = 21). BIMU8 was not sufficient to reverse respiratory depression by fentanyl. (B) The AMPA positive allosteric modulator CX614 (5 mM) and fentanyl (n = 6) were also compared to fentanyl alone (n = 7) or control (n = 7). CX614 + fentanyl group showed significantly higher respiratory rate than fentanyl, DMSO, and control. (C) The analgesic lidocaine (n = 4) was compared to DMSO (0.0016%) (n = 5) and control (n = 5) and showed lower respiratory rate than the control group. Normalized data are presented as means ± standard deviations. Circles indicate individual data points for each zebrafish measured. Black lines and * indicate groups significantly different with p<0.05. Source data can be found in Figure 4—source data 1. The online version of this article includes the following source data for figure 4:
    Figure Legend Snippet: Figure 4. Respiratory depression and respiratory stimulants in larval zebrafish. (A) The respiratory stimulant BIMU8 (10 mM), a 5-HT4A serotonin receptor agonist, in combination with fentanyl (n = 20) was compared to fentanyl alone (n = 4) or BIMU8 alone (n = 21). BIMU8 was not sufficient to reverse respiratory depression by fentanyl. (B) The AMPA positive allosteric modulator CX614 (5 mM) and fentanyl (n = 6) were also compared to fentanyl alone (n = 7) or control (n = 7). CX614 + fentanyl group showed significantly higher respiratory rate than fentanyl, DMSO, and control. (C) The analgesic lidocaine (n = 4) was compared to DMSO (0.0016%) (n = 5) and control (n = 5) and showed lower respiratory rate than the control group. Normalized data are presented as means ± standard deviations. Circles indicate individual data points for each zebrafish measured. Black lines and * indicate groups significantly different with p<0.05. Source data can be found in Figure 4—source data 1. The online version of this article includes the following source data for figure 4:

    Techniques Used: Control

    Figure 7. Analgesic profiles of larval zebrafish. (A) To determine whether the analgesia assay can be replicated with non-opioid analgesics, we used lidocaine, an analgesic widely used in the clinic. Lidocaine with formalin (n = 19) only moderately reduced swimming velocity compared to formalin alone (n = 10). (B) The respiratory stimulant BIMU8 administered with fentanyl and formalin (n = 17) did not significantly affect swimming velocity when compared to formalin/fentanyl (n = 8). On the other hand, CX614/formalin/fentanyl (n = 12) presented significant differences compared to the control (n = 21). (C) We also looked at the analgesic properties of fentanyl in Tu¨ bingen zebrafish. As observed with the respiratory assays, fentanyl (n = 10) did not reduce the swimming response compared to formalin alone (n = 9) as it did with AB zebrafish. All data are presented as medians with error bars showing 25th and 75th percentile or interquartile range. Circles indicate individual data points for each zebrafish measured. * indicates groups significantly different with p<0.05. Source data can be found in Figure 7—source data 1. The online version of this article includes the following source data and figure supplement(s) for figure 7:
    Figure Legend Snippet: Figure 7. Analgesic profiles of larval zebrafish. (A) To determine whether the analgesia assay can be replicated with non-opioid analgesics, we used lidocaine, an analgesic widely used in the clinic. Lidocaine with formalin (n = 19) only moderately reduced swimming velocity compared to formalin alone (n = 10). (B) The respiratory stimulant BIMU8 administered with fentanyl and formalin (n = 17) did not significantly affect swimming velocity when compared to formalin/fentanyl (n = 8). On the other hand, CX614/formalin/fentanyl (n = 12) presented significant differences compared to the control (n = 21). (C) We also looked at the analgesic properties of fentanyl in Tu¨ bingen zebrafish. As observed with the respiratory assays, fentanyl (n = 10) did not reduce the swimming response compared to formalin alone (n = 9) as it did with AB zebrafish. All data are presented as medians with error bars showing 25th and 75th percentile or interquartile range. Circles indicate individual data points for each zebrafish measured. * indicates groups significantly different with p<0.05. Source data can be found in Figure 7—source data 1. The online version of this article includes the following source data and figure supplement(s) for figure 7:

    Techniques Used: Control

    Related Articles

    Control:

    Article Title: Respiratory depression and analgesia by opioid drugs in freely behaving larval zebrafish
    Article Snippet: The MOR antagonist CTAP (D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH 2 ), lidocaine, the Ampakine CX614, and the 5-HT 4A receptor agonist BIMU8 were obtained from Tocris (ON, Canada).

    Article Title: Respiratory depression and analgesia by opioid drugs in freely behaving larval zebrafish
    Article Snippet: The MOR antagonist CTAP (D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2), lidocaine, the Ampakine CX614, and the 5-HT4A receptor agonist BIMU8 were obtained from Tocris (ON, Canada).



    Similar Products

    93
    Tocris ampakine cx614
    Figure 4. Respiratory depression and respiratory stimulants in larval zebrafish. (A) The respiratory stimulant BIMU8 (10 mM), a 5-HT4A serotonin receptor agonist, in combination with fentanyl (n = 20) was compared to fentanyl alone (n = 4) or BIMU8 alone (n = 21). BIMU8 was not sufficient to reverse respiratory depression by fentanyl. (B) The AMPA positive allosteric modulator <t>CX614</t> (5 mM) and fentanyl (n = 6) were also compared to fentanyl alone (n = 7) or control (n = 7). CX614 + fentanyl group showed significantly higher respiratory rate than fentanyl, DMSO, and control. (C) The analgesic lidocaine (n = 4) was compared to DMSO (0.0016%) (n = 5) and control (n = 5) and showed lower respiratory rate than the control group. Normalized data are presented as means ± standard deviations. Circles indicate individual data points for each zebrafish measured. Black lines and * indicate groups significantly different with p<0.05. Source data can be found in Figure 4—source data 1. The online version of this article includes the following source data for figure 4:
    Ampakine Cx614, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ampakine+cx614/CX+614/10__7554_slash_elife__63407-303-7-18
    Average 93 stars, based on 1 article reviews
    ampakine cx614 - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    90
    Cortex Pharmaceuticals ampakine cx614
    Local field potential recording and analysis during Y-maze exploration. (a)) Behavior testing schedule. Each animal explored the maze for 8 min on each day at P18, 19, 23, and 24. Either <t>CX614</t> (2.5 mg/kg) or vehicle (counterbalanced within animal) was administered 30 min prior to the trial on each testing day. (b) Representative unfiltered local field potential activity during 1 s of maze exploration from one trial, showing location of lowermost electrode in stratum radiatum of hippocampal area CA1. Scale bar is 0.1 ms and 2 mV. (c) Snapshot of video captured during Y-maze exploration. (d) Time-frequency varying power of signal in (b) following convolution with Morlet wavelets and z-scoring. Discrete activity in different wavebands (theta, 4–12 Hz; slow gamma, 25–55 Hz; fast gamma, 65–100 Hz) is apparent. (e) Representative Nissl stained coronal section of an implanted brain showing probe tract terminating in stratum radiatum
    Ampakine Cx614, supplied by Cortex Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ampakine+cx614/cx614/pmc08526138-119-2-7
    Average 90 stars, based on 1 article reviews
    ampakine cx614 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Tocris ampakines cx614
    Local field potential recording and analysis during Y-maze exploration. (a)) Behavior testing schedule. Each animal explored the maze for 8 min on each day at P18, 19, 23, and 24. Either <t>CX614</t> (2.5 mg/kg) or vehicle (counterbalanced within animal) was administered 30 min prior to the trial on each testing day. (b) Representative unfiltered local field potential activity during 1 s of maze exploration from one trial, showing location of lowermost electrode in stratum radiatum of hippocampal area CA1. Scale bar is 0.1 ms and 2 mV. (c) Snapshot of video captured during Y-maze exploration. (d) Time-frequency varying power of signal in (b) following convolution with Morlet wavelets and z-scoring. Discrete activity in different wavebands (theta, 4–12 Hz; slow gamma, 25–55 Hz; fast gamma, 65–100 Hz) is apparent. (e) Representative Nissl stained coronal section of an implanted brain showing probe tract terminating in stratum radiatum
    Ampakines Cx614, supplied by Tocris, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ampakine+cx614/cx614/pm30837875-70-1-4
    Average 90 stars, based on 1 article reviews
    ampakines cx614 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    Figure 4. Respiratory depression and respiratory stimulants in larval zebrafish. (A) The respiratory stimulant BIMU8 (10 mM), a 5-HT4A serotonin receptor agonist, in combination with fentanyl (n = 20) was compared to fentanyl alone (n = 4) or BIMU8 alone (n = 21). BIMU8 was not sufficient to reverse respiratory depression by fentanyl. (B) The AMPA positive allosteric modulator CX614 (5 mM) and fentanyl (n = 6) were also compared to fentanyl alone (n = 7) or control (n = 7). CX614 + fentanyl group showed significantly higher respiratory rate than fentanyl, DMSO, and control. (C) The analgesic lidocaine (n = 4) was compared to DMSO (0.0016%) (n = 5) and control (n = 5) and showed lower respiratory rate than the control group. Normalized data are presented as means ± standard deviations. Circles indicate individual data points for each zebrafish measured. Black lines and * indicate groups significantly different with p<0.05. Source data can be found in Figure 4—source data 1. The online version of this article includes the following source data for figure 4:

    Journal: eLife

    Article Title: Respiratory depression and analgesia by opioid drugs in freely behaving larval zebrafish

    doi: 10.7554/elife.63407

    Figure Lengend Snippet: Figure 4. Respiratory depression and respiratory stimulants in larval zebrafish. (A) The respiratory stimulant BIMU8 (10 mM), a 5-HT4A serotonin receptor agonist, in combination with fentanyl (n = 20) was compared to fentanyl alone (n = 4) or BIMU8 alone (n = 21). BIMU8 was not sufficient to reverse respiratory depression by fentanyl. (B) The AMPA positive allosteric modulator CX614 (5 mM) and fentanyl (n = 6) were also compared to fentanyl alone (n = 7) or control (n = 7). CX614 + fentanyl group showed significantly higher respiratory rate than fentanyl, DMSO, and control. (C) The analgesic lidocaine (n = 4) was compared to DMSO (0.0016%) (n = 5) and control (n = 5) and showed lower respiratory rate than the control group. Normalized data are presented as means ± standard deviations. Circles indicate individual data points for each zebrafish measured. Black lines and * indicate groups significantly different with p<0.05. Source data can be found in Figure 4—source data 1. The online version of this article includes the following source data for figure 4:

    Article Snippet: The MOR antagonist CTAP (D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2), lidocaine, the Ampakine CX614, and the 5-HT4A receptor agonist BIMU8 were obtained from Tocris (ON, Canada).

    Techniques: Control

    Figure 7. Analgesic profiles of larval zebrafish. (A) To determine whether the analgesia assay can be replicated with non-opioid analgesics, we used lidocaine, an analgesic widely used in the clinic. Lidocaine with formalin (n = 19) only moderately reduced swimming velocity compared to formalin alone (n = 10). (B) The respiratory stimulant BIMU8 administered with fentanyl and formalin (n = 17) did not significantly affect swimming velocity when compared to formalin/fentanyl (n = 8). On the other hand, CX614/formalin/fentanyl (n = 12) presented significant differences compared to the control (n = 21). (C) We also looked at the analgesic properties of fentanyl in Tu¨ bingen zebrafish. As observed with the respiratory assays, fentanyl (n = 10) did not reduce the swimming response compared to formalin alone (n = 9) as it did with AB zebrafish. All data are presented as medians with error bars showing 25th and 75th percentile or interquartile range. Circles indicate individual data points for each zebrafish measured. * indicates groups significantly different with p<0.05. Source data can be found in Figure 7—source data 1. The online version of this article includes the following source data and figure supplement(s) for figure 7:

    Journal: eLife

    Article Title: Respiratory depression and analgesia by opioid drugs in freely behaving larval zebrafish

    doi: 10.7554/elife.63407

    Figure Lengend Snippet: Figure 7. Analgesic profiles of larval zebrafish. (A) To determine whether the analgesia assay can be replicated with non-opioid analgesics, we used lidocaine, an analgesic widely used in the clinic. Lidocaine with formalin (n = 19) only moderately reduced swimming velocity compared to formalin alone (n = 10). (B) The respiratory stimulant BIMU8 administered with fentanyl and formalin (n = 17) did not significantly affect swimming velocity when compared to formalin/fentanyl (n = 8). On the other hand, CX614/formalin/fentanyl (n = 12) presented significant differences compared to the control (n = 21). (C) We also looked at the analgesic properties of fentanyl in Tu¨ bingen zebrafish. As observed with the respiratory assays, fentanyl (n = 10) did not reduce the swimming response compared to formalin alone (n = 9) as it did with AB zebrafish. All data are presented as medians with error bars showing 25th and 75th percentile or interquartile range. Circles indicate individual data points for each zebrafish measured. * indicates groups significantly different with p<0.05. Source data can be found in Figure 7—source data 1. The online version of this article includes the following source data and figure supplement(s) for figure 7:

    Article Snippet: The MOR antagonist CTAP (D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2), lidocaine, the Ampakine CX614, and the 5-HT4A receptor agonist BIMU8 were obtained from Tocris (ON, Canada).

    Techniques: Control

    Local field potential recording and analysis during Y-maze exploration. (a)) Behavior testing schedule. Each animal explored the maze for 8 min on each day at P18, 19, 23, and 24. Either CX614 (2.5 mg/kg) or vehicle (counterbalanced within animal) was administered 30 min prior to the trial on each testing day. (b) Representative unfiltered local field potential activity during 1 s of maze exploration from one trial, showing location of lowermost electrode in stratum radiatum of hippocampal area CA1. Scale bar is 0.1 ms and 2 mV. (c) Snapshot of video captured during Y-maze exploration. (d) Time-frequency varying power of signal in (b) following convolution with Morlet wavelets and z-scoring. Discrete activity in different wavebands (theta, 4–12 Hz; slow gamma, 25–55 Hz; fast gamma, 65–100 Hz) is apparent. (e) Representative Nissl stained coronal section of an implanted brain showing probe tract terminating in stratum radiatum

    Journal: Hippocampus

    Article Title: Hippocampal gamma rhythms during Y-maze navigation in the juvenile rat

    doi: 10.1002/hipo.23168

    Figure Lengend Snippet: Local field potential recording and analysis during Y-maze exploration. (a)) Behavior testing schedule. Each animal explored the maze for 8 min on each day at P18, 19, 23, and 24. Either CX614 (2.5 mg/kg) or vehicle (counterbalanced within animal) was administered 30 min prior to the trial on each testing day. (b) Representative unfiltered local field potential activity during 1 s of maze exploration from one trial, showing location of lowermost electrode in stratum radiatum of hippocampal area CA1. Scale bar is 0.1 ms and 2 mV. (c) Snapshot of video captured during Y-maze exploration. (d) Time-frequency varying power of signal in (b) following convolution with Morlet wavelets and z-scoring. Discrete activity in different wavebands (theta, 4–12 Hz; slow gamma, 25–55 Hz; fast gamma, 65–100 Hz) is apparent. (e) Representative Nissl stained coronal section of an implanted brain showing probe tract terminating in stratum radiatum

    Article Snippet: The AMPAKINE, CX614 (a kind gift from Cortex Pharmaceuticals), was dissolved in (2-hydroxypropyl)-β-cyclodextrin (Sigma-Aldrich) solution (equal parts phosphate-buffered saline (PBS), sterile water, and cyclodextrin powder) immediately prior to use.

    Techniques: Activity Assay, Staining